No more beta-blockers after AMI? The results of the REDUCE-AMI trial
07/05/24 • 13 min
With Sean van Depen, University of Alberta, Edmonton - Canada, and Bertil Lindahl, Uppsala University, Uppsala - Sweden.
Highlights from the REDUCE-AMI trial.
With Sean van Depen, University of Alberta, Edmonton - Canada, and Bertil Lindahl, Uppsala University, Uppsala - Sweden.
Highlights from the REDUCE-AMI trial.
Previous Episode
What have we learned from the DanGer Shock trial?
With David Morrow, Brigham and Women's Hospital, Boston - United States of America & Christian Hassager, Rigshospitalet - Copenhagen University Hospital, Copenhagen - Denmark.
Results of a breakthrough study on circulatory support in patients with AMI-CS.
Next Episode
Anticoagulation in MCS
With Hannah Schaubroeck, ICU, Ghent University Hospital - Belgium, and Christophe Vandenbriele, Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London - UK and OLV Hospital, Aalst - Belgium.
Challenges associated with the anticoagulation and hemostasis disorders during MCS.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/acvc-cardio-talk-495411/no-more-beta-blockers-after-ami-the-results-of-the-reduce-ami-trial-65623287"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to no more beta-blockers after ami? the results of the reduce-ami trial on goodpods" style="width: 225px" /> </a>
Copy